Celent Buy Side Risk Impact Note
Celent Buy Side Risk Impact Note
Celent Buy Side Risk Impact Note
s
E
x
p
e
r
t
i
s
e
15
LEVERAGING CELENTS EXPERTISE
If you found this report valuable, you might consider engaging with Celent for custom
analysis and research. Our collective experience and the knowledge we gained while
working on this report can help you streamline the creation, refinement, or execution of
your strategies.
SUPPORT FOR FINANCIAL INSTITUTIONS
Typical projects we support related to capital markets, finance and risk include:
Vendor short listing and selection. We perform discovery specific to you and your
business to better understand your unique needs. We then create and administer a
custom RFI to selected vendors to assist you in making rapid and accurate vendor
choices.
Business practice evaluations. We spend time evaluating your business processes.
Based on our knowledge of the market, we identify potential process or technology
constraints and provide clear insights that will help you implement industry best practices.
IT and business strategy creation. We collect perspectives from your executive team,
your front line business and IT staff, and your customers. We then analyze your current
position, institutional capabilities, and technology against your goals. If necessary, we
help you reformulate your technology and business plans to address short-term and long-
term needs.
SUPPORT FOR VENDORS
We provide services that help you refine your product and service offerings. Examples
include:
Product and service strategy evaluation. We help you assess your market position in
terms of functionality, technology, and services. Our strategy workshops will help you
target the right customers and map your offerings to their needs.
Market messaging and collateral review. Based on our extensive experience with your
potential clients, we assess your marketing and sales materialsincluding your website
and any collateral.
C
h
a
p
t
e
r
:
R
e
l
a
t
e
d
C
e
l
e
n
t
R
e
s
e
a
r
c
h
16
RELATED CELENT RESEARCH
Less Stressful Stress-Testing: Challenges, Best Practices, and Innovation
April 2014
Portfolio Analytics and Risk Management Solutions for the Buy Side: Storm-Proofing for
Growth and Resilience
March 2014
Risk Management Outlook 2014: Trends, Tensions, and Transformations in the Value
Chain
February 2014
Buy Side Portfolio and Risk Management: Keeping a Sharp Eye on Risk, Returns, and
Perfect Storms
November 2013
Strategic Innovations in Risk Management (Part 3): Sniffing Out the Trail to Game
Changers
October 2013
Strategic Innovations in Risk Management (Part 2): Architectural Strategies for Growth
September 2013
Strategic Innovations in Risk Management (Part 1): Compliance 1, Innovation 0
August 2013
The Age of Trade Lifecycle Optimization in Securities Trading: Moving from Theory to
Practice
August 2013
The Risk Data Agenda: A New Priority
July 2013
Liquidity Management: Balancing Regulation with Business
June 2013
Maximizing Collateral Advantage: A Survey of Buy Side Business and Operational
Strategies
May 2013
Defining Your Risk Appetite: The Importance of Taking a Quantitative and Qualitative
Approach
March 2013
Derivatives Pricing and Risk Analytics: Industrializing Derivatives Markets
February 2013
A Money and Information Business: The State of the Financial Services Industry 2013
January 2013
Copyright Notice
Prepared by
Celent, a division of Oliver Wyman, Inc.
Copyright 2014 Celent, a division of Oliver Wyman, Inc. All rights reserved. This report
may not be reproduced, copied or redistributed, in whole or in part, in any form or by any
means, without the written permission of Celent, a division of Oliver Wyman (Celent)
and Celent accepts no liability whatsoever for the actions of third parties in this respect.
Celent is the sole copyright owner of this report, and any use of this report by any third
party is strictly prohibited without a license expressly granted by Celent. This report is not
intended for general circulation, nor is it to be used, reproduced, copied, quoted or
distributed by third parties for any purpose other than those that may be set forth herein
without the prior written permission of Celent. Neither all nor any part of the contents of
this report, or any opinions expressed herein, shall be disseminated to the public through
advertising media, public relations, news media, sales media, mail, direct transmittal, or
any other public means of communications, without the prior written consent of Celent.
Any violation of Celents rights in this report will be enforced to the fullest extent of the
law, including the pursuit of monetary damages and injunctive relief in the event of any
breach of the foregoing restrictions.
This report is not a substitute for tailored professional advice on how a specific financial
institution should execute its strategy. This report is not investment advice and should not
be relied on for such advice or as a substitute for consultation with professional
accountants, tax, legal or financial advisers. Celent has made every effort to use reliable,
up-to-date and comprehensive information and analysis, but all information is provided
without warranty of any kind, express or implied. Information furnished by others, upon
which all or portions of this report are based, is believed to be reliable but has not been
verified, and no warranty is given as to the accuracy of such information. Public
information and industry and statistical data, are from sources we deem to be reliable;
however, we make no representation as to the accuracy or completeness of such
information and have accepted the information without further verification.
Celent disclaims any responsibility to update the information or conclusions in this report.
Celent accepts no liability for any loss arising from any action taken or refrained from as a
result of information contained in this report or any reports or sources of information
referred to herein, or for any consequential, special or similar damages even if advised of
the possibility of such damages.
There are no third party beneficiaries with respect to this report, and we accept no liability
to any third party. The opinions expressed herein are valid only for the purpose stated
herein and as of the date of this report.
No responsibility is taken for changes in market conditions or laws or regulations and no
obligation is assumed to revise this report to reflect changes, events or conditions, which
occur subsequent to the date hereof.
For more information please contact info@celent.com or:
Cubillas Ding cding@celent.com
NORTH AMERICA EUROPE ASIA
USA
200 Clarendon Street, 12th Floor
Boston, MA 02116
Tel.: +1.617.262.3120
Fax: +1.617.262.3121
France
28, avenue Victor Hugo
75783 Paris Cedex 16
Tel.: +33.1.73.04.46.19
Fax: +33.1.45.02.30.01
Japan
The Imperial Hotel Tower, 13th Floor
1-1-1 Uchisaiwai-cho
Chiyoda-ku, Tokyo 100-0011
Tel: +81.3.3500.3023
Fax: +81.3.3500.3059
USA
1166 Avenue of the Americas
New York, NY 10036
Tel.: +1.212.541.8100
Fax: +1.212.541.8957
Germany
Marstallstrasse 11
80539 Munich
Tel: +49.89.242.68.581
Fax: +49 89.939.495.21
China
Beijing Kerry Centre
South Tower, 15th Floor
1 Guanghua Road
Chaoyang, Beijing 100022
Tel: +86.10.8520.0350
Fax: +86.10.8520.0349
USA
Four Embarcadero Center, Suite 1100
San Francisco, CA 94111
Tel.: +1.415.743.7900
Fax: +1.415.743.7950
United Kingdom
55 Baker Street
London W1U 8EW
Tel.: +44.20.7333.8333
Fax: +44.20.7333.8334